Comparative Pharmacology
Head-to-head clinical analysis: INFUVITE PEDIATRIC PHARMACY BULK PACKAGE versus MULTIFUGE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INFUVITE PEDIATRIC PHARMACY BULK PACKAGE versus MULTIFUGE.
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) vs MULTIFUGE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
INFUVITE PEDIATRIC is a multivitamin formulation providing essential vitamins for metabolic processes, serving as cofactors in enzymatic reactions (e.g., B vitamins in energy metabolism, vitamin A in vision, vitamin D in calcium homeostasis).
Multifuge is a combination product containing an antihistamine and a decongestant. The antihistamine (chlorpheniramine) competitively antagonizes histamine H1 receptors, reducing allergic symptoms. The decongestant (pseudoephedrine) stimulates alpha-adrenergic receptors, causing vasoconstriction and reducing nasal congestion.
Not applicable; INFUVITE PEDIATRIC is indicated for pediatric patients (≤11 years old). For adult use, consider adult multivitamin products.
IV: 10 mg/kg body weight as a single dose; repeated every 48 hours as needed.
None Documented
None Documented
Variable; thiamine ~18 min, riboflavin ~1.1 h, pyridoxine ~2.5 h, ascorbic acid ~16 d, vitamin A ~18 d (fat-soluble storage).
The terminal elimination half-life is 7-9 hours in adults with normal renal function. This may be prolonged (up to 20-30 hours) in patients with severe renal impairment (CrCl <30 mL/min), necessitating dose adjustment.
Renal excretion of water-soluble vitamins; fat-soluble vitamins (A, D, E, K) are excreted in bile/feces; minimal unchanged renal elimination.
Renal excretion of unchanged drug accounts for 60-70% of the administered dose, with the remainder undergoing hepatic metabolism to inactive metabolites that are excreted renally. Fecal elimination is minimal (<5%).
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement